Investor Information Overview

Sucampo Pharmaceuticals, Inc., a global biopharmaceutical company based in Bethesda, MD, focuses on the development and commercialization of medicines based on prostones. The therapeutic potential of prostones, which are bio-lipids that occur naturally in the human body, was first identified by Ryuji Ueno, M.D., Ph.D., Sucampo Pharmaceuticals’ chairman and chief executive officer. Dr. Ueno founded Sucampo Pharmaceut  More >>

SCMP (Common Stock) Exchange NASDAQ GM (US Dollar) Price $3.39 Change (%)   0.02 (0.59%) Volume 20,200 Data as of 02/08/10 4:00 p.m. ET Minimum 20 minute delay Refresh quote

Recent News

| More >>

Date Title   11/25/09 Sucampo Announces Lubiprostone Data Presented at GASTRO 2009 UEGF/WCOG 11/19/09 Sucampo Receives Marketing Authorization for Amitiza(R) in Switzerland for Treatment of Chronic Idiopathic Constipation 11/06/09 Sucampo Pharmaceuticals Invites Investors to Listen to Webcast of Presentation at Credit Suisse Conference 11/05/09 Sucampo Pharmaceuticals Reports Financial Results for the Third Quarter of 2009